BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 31175222)

  • 1. Prevalence of and risk factors for acute laminitis in horses treated with corticosteroids.
    Potter K; Stevens K; Menzies-Gow N
    Vet Rec; 2019 Jul; 185(3):82. PubMed ID: 31175222
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of supporting limb laminitis in a UK equine practice and referral hospital setting between 2005 and 2013: implications for future epidemiological studies.
    Wylie CE; Newton JR; Bathe AP; Payne RJ
    Vet Rec; 2015 Jan; 176(3):72. PubMed ID: 25261271
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intrasynovial triamcinolone treatment is not associated with incidence of acute laminitis.
    Haseler CJ; Jarvis GE; McGovern KF
    Equine Vet J; 2021 Sep; 53(5):895-901. PubMed ID: 33174264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk factors for development of acute laminitis in horses during hospitalization: 73 cases (1997-2004).
    Parsons CS; Orsini JA; Krafty R; Capewell L; Boston R
    J Am Vet Med Assoc; 2007 Mar; 230(6):885-9. PubMed ID: 17362165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence and risk factors for laminitis within the Norwegian pony breed Nordlandshest/Lyngshest.
    Lykkjen S; Stenbakk LK; Holmøy IH
    Acta Vet Scand; 2023 Jun; 65(1):22. PubMed ID: 37328910
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The prevalence of endocrinopathic laminitis among horses presented for laminitis at a first-opinion/referral equine hospital.
    Karikoski NP; Horn I; McGowan TW; McGowan CM
    Domest Anim Endocrinol; 2011 Oct; 41(3):111-7. PubMed ID: 21696910
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A multicenter, matched case-control study of risk factors for equine laminitis.
    Alford P; Geller S; Richrdson B; Slater M; Honnas C; Foreman J; Robinson J; Messer M; Roberts M; Goble D; Hood D; Chaffin M
    Prev Vet Med; 2001 May; 49(3-4):209-22. PubMed ID: 11311954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disease and pharmacologic risk factors for first and subsequent episodes of equine laminitis: A cohort study of free-text electronic medical records.
    Welsh CE; Duz M; Parkin TDH; Marshall JF
    Prev Vet Med; 2017 Jan; 136():11-18. PubMed ID: 28010903
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence and factors associated with development of laminitis in horses with duodenitis/proximal jejunitis: 33 cases (1985-1991).
    Cohen ND; Parson EM; Seahorn TL; Carter GK
    J Am Vet Med Assoc; 1994 Jan; 204(2):250-4. PubMed ID: 8144386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence of laminitis and survey of dietary and management practices in pleasure horses and ponies in south-eastern Australia.
    Potter SJ; Bamford NJ; Harris PA; Bailey SR
    Aust Vet J; 2017 Oct; 95(10):370-374. PubMed ID: 28948628
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of suspected pituitary pars intermedia dysfunction in horses with laminitis.
    Donaldson MT; Jorgensen AJ; Beech J
    J Am Vet Med Assoc; 2004 Apr; 224(7):1123-7. PubMed ID: 15074858
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does oral prednisolone treatment increase the incidence of acute laminitis?
    Jordan VJ; Ireland JL; Rendle DI
    Equine Vet J; 2017 Jan; 49(1):19-25. PubMed ID: 26713748
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of modifiable factors associated with owner-reported equine laminitis in Britain using a web-based cohort study approach.
    Pollard D; Wylie CE; Verheyen KLP; Newton JR
    BMC Vet Res; 2019 Feb; 15(1):59. PubMed ID: 30755193
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Case-control study of risk factors for pasture-and endocrinopathy-associated laminitis in North American horses.
    Coleman MC; Belknap JK; Eades SC; Galantino-Homer HL; Hunt RJ; Geor RJ; McCue ME; McIlwraith CW; Moore RM; Peroni JF; Townsend HG; White NA; Cummings KJ; Ivanek-Miojevic R; Cohen ND
    J Am Vet Med Assoc; 2018 Aug; 253(4):470-478. PubMed ID: 30058970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Age, breed, sex and seasonality as risk factors for equine laminitis.
    Polzer J; Slater MR
    Prev Vet Med; 1997 Jan; 29(3):179-84. PubMed ID: 9234403
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decision-tree analysis of clinical data to aid diagnostic reasoning for equine laminitis: a cross-sectional study.
    Wylie CE; Shaw DJ; Verheyen KL; Newton JR
    Vet Rec; 2016 Apr; 178(17):420. PubMed ID: 26969668
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidemiological study of pasture-associated laminitis and concurrent risk factors in the South of England.
    Menzies-Gow NJ; Katz LM; Barker KJ; Elliott J; De Brauwere MN; Jarvis N; Marr CM; Pfeiffer DU
    Vet Rec; 2010 Oct; 167(18):690-4. PubMed ID: 21257484
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictors of laminitis development in a cohort of nonlaminitic ponies.
    Knowles EJ; Elliott J; Harris PA; Chang YM; Menzies-Gow NJ
    Equine Vet J; 2023 Jan; 55(1):12-23. PubMed ID: 35263471
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A cohort study of equine laminitis in Great Britain 2009-2011: estimation of disease frequency and description of clinical signs in 577 cases.
    Wylie CE; Collins SN; Verheyen KL; Newton JR
    Equine Vet J; 2013 Nov; 45(6):681-7. PubMed ID: 23489181
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Descriptive epidemiological study of equine laminitis.
    Slater MR; Hood DM; Carter GK
    Equine Vet J; 1995 Sep; 27(5):364-7. PubMed ID: 8654351
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.